Abbott Gets FDA Clearance for Alinity M STI Assay

By Chris Wack

Abbott Laboratories received clearance from the U.S. Food and Drug Administration for its Alinity m STI Assay, the company said Wednesday.

The test simultaneously detects and differentiates four common sexually transmitted infections--Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium--and requires one swab sample or a urine sample collected in a healthcare setting by either a clinician or by the patient, the company said.

The test runs on Abbott's Alinity m system, a high-volume laboratory molecular instrument.

Write to Chris Wack at [e-mail]

(END) Dow Jones Newswires

05-04-22 0927ET